Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) Invested Capital (2019 - 2025)

Cellebrite DI's Invested Capital history spans 7 years, with the latest figure at $484.3 million for Q4 2025.

  • Quarterly Invested Capital rose 44.13% to $484.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $484.3 million through Dec 2025, up 44.13% year-over-year, with the annual reading at $484.3 million for FY2025, 44.13% up from the prior year.
  • Invested Capital came in at $484.3 million for Q4 2025, up from $447.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $484.3 million in Q4 2025 to a low of -$73.3 million in Q4 2021.
  • The 5-year median for Invested Capital is $56.6 million (2022), against an average of $173.5 million.
  • Year-over-year, Invested Capital tumbled 214.96% in 2021 and then soared 1461.09% in 2025.
  • Cellebrite DI's Invested Capital stood at -$73.3 million in 2021, then soared by 200.71% to $73.9 million in 2022, then plummeted by 53.68% to $34.2 million in 2023, then surged by 882.17% to $336.0 million in 2024, then surged by 44.13% to $484.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Invested Capital are $484.3 million (Q4 2025), $447.7 million (Q3 2025), and $408.4 million (Q2 2025).